---
created: 2025-04-13
updated: 2025-04-13T10:52
id: Emx?lj!*y?
specialty: pharmaco
specialty_id: 256
tags:
  - source/ak-original-decks::step-1::zanki-pharmacology
  - "source/ak-step1-v11:": 
  - theme/b&b::11-hematology::01-hemostasis::07-anticoagulants
  - "source/ak-step1-v11:": 
  - theme/firstaid::02-immunology::04-immunosuppressants::04-therapeutic-antibodies
  - "source/ak-step1-v11:": 
  - theme/firstaid::02-immunology::04-immunosuppressants::04-therapeutic-antibodies::abciximab
  - "source/ak-step1-v11:": 
  - theme/firstaid::10-hematology-oncology::05-pharm::08-glycoprotein-iib/iiia-inhibitors
  - "source/ak-step1-v11:": 
  - theme/nbme::29
  - "source/ak-step1-v11:": 
  - source/ome-banner::basic-science::13-hematology-oncology::11-hemostasis
  - "source/ak-step1-v11:": 
  - theme/physeo::09-pharm::17-hem/onc-pharm::glycoprotein-iib/iiia-ihibitors
  - "source/ak-step1-v11:": 
  - theme/pixorize::03-pharm::10-heme::glycoprotein-iib/iiia-inhibitors
  - "source/ak-step1-v11:": 
  - theme/sketchypharm::03-blood-&-inflammation::01-anticoagulants-&-thrombolytics::03-antiplatelet-agents
  - "source/ak-step1-v11:": 
  - theme/uworld::1000-9999::1000-1999::1079
  - source/ak-step1-v11::^other::^highyield::2-relativelyhighyield
type: flashcard
---

# Question
**Abciximab** is a monoclonal IgG antibody against the GPIIb/IIIa receptor, preventing binding of fibrinogen to platelets

---

# Answer
made from monoclonal antibody Fab fragments; tx = Glanzmann thrombasthenia = defect in GP IIb/IIIa receptor == mucocutaneous bleeding *childhood* = primary hemostasis defect   - normally, GB IIb/IIIa promotes PLT binding to fibrinogen to form the PLT plug